StockData
West Pharmaceutical Services Inc logo

West Pharmaceutical Services Inc (WST) stock

WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3028% above fair value
$404.02−10.10 (-2.44%)

Close on Nov 18, 2026Market cap $28.14BP/E 45.3Yield 0.21%

West Pharmaceutical Services pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

West Pharmaceutical Services's pe ratio was 52.9× on Nov 11, 2026, against 41.1× a year earlier. Over the last 5 years it ranged from 25.6× to 59.3×, with a median of 43.7×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202652.9×+12.0
2025Dec 31, 202540.8×−7.8
2024Dec 31, 202448.6×+1.1
2023Dec 29, 202347.5×+19.0
2022Dec 30, 202228.5×−29.7
2021Dec 31, 202158.2×−10.4
2020Dec 31, 202068.6×+38.7
2015Jan 30, 201529.9×−2.4
2014Dec 31, 201432.3×+0.6
2013Dec 31, 201331.7×+7.0
2012Dec 31, 201224.7×+3.8
2011Dec 30, 201120.9×+6.3
2010Jan 29, 201014.5×−1.1
2009Dec 31, 200915.7×–

More West Pharmaceutical Services figures

See a number that looks wrong?